These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 17294849

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 23. Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.
    Vuaroqueaux V, Urban P, Labuhn M, Delorenzi M, Wirapati P, Benz CC, Flury R, Dieterich H, Spyratos F, Eppenberger U, Eppenberger-Castori S.
    Breast Cancer Res; 2007 Aug 01; 9(3):R33. PubMed ID: 17535433
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients.
    Florena AM, Tripodo C, Guarnotta C, Ingrao S, Porcasi R, Martorana A, Lo Bosco G, Cabibi D, Franco V.
    Pathobiology; 2007 Aug 01; 74(6):317-22. PubMed ID: 18087195
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.
    Eroles P, Bosch A, Pérez-Fidalgo JA, Lluch A.
    Cancer Treat Rev; 2012 Oct 01; 38(6):698-707. PubMed ID: 22178455
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Breast carcinoma: is molecular evaluation a necessary part of current pathological analysis?
    Koka R, Ioffe OB.
    Semin Diagn Pathol; 2013 Nov 01; 30(4):321-8. PubMed ID: 24342288
    [Abstract] [Full Text] [Related]

  • 36. Correlation between imaging and molecular classification of breast cancers.
    Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H, Mac Grogan G.
    Diagn Interv Imaging; 2013 Nov 01; 94(11):1069-80. PubMed ID: 23867597
    [Abstract] [Full Text] [Related]

  • 37. [WHO classification of tumors of the breast, 2012].
    Frank GA, Danilova NV, Andreeva IuIu, Nefedova NA.
    Arkh Patol; 2013 Nov 01; 75(2):53-63. PubMed ID: 24006766
    [Abstract] [Full Text] [Related]

  • 38. [Clinico-pathological nosology of malignant tumors of the breast].
    Berta V, Perelli-Ercolini M, Beani G.
    Chir Ital; 1980 Dec 01; 32(6):1478-83. PubMed ID: 7249206
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Tumor classification using the TNM system. Sequel 1: breast cancer].
    Susemihl D.
    Fortschr Med; 1975 Dec 18; 93(35-36):1759-63. PubMed ID: 1222933
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.